Methods Serum CA125 levels were determined with MEIA and serum SIL-2R with EIA in 36 patients with ovarian cancer, 51 patients with benign gynecologic tumor as well as 35 controls.

• 方法 :应用微粒子酶免疫分析法 (MEIA)和酶联吸附法对 36例卵巢癌患者和 5 1例妇科良性肿瘤患者进行了血清CA1 2 5和SIL - 2R水平检测 ,并以 35名正常健康人作对照。